AAAAAA

   
Results: 1-10 |
Results: 10
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
Authors: Kakolyris, S Papadakis, E Tsiafaki, X Kalofonos, C Rapti, A Toubis, M Bania, E Kouroussis, C Chainis, K Androulakis, N Agelaki, S Sarra, E Vardakis, N Georgoulias, V
Citation: S. Kakolyris et al., Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study, LUNG CANC, 32(2), 2001, pp. 179-187
A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors
Authors: Kakolyris, S Kouroussis, C Souglakos, J Mavroudis, D Agelaki, S Kalbakis, K Androulakis, N Vardakis, N Vamvakas, L Georgoulias, V
Citation: S. Kakolyris et al., A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors, ONCOL-BASEL, 61(4), 2001, pp. 265-270
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study
Authors: Kouroussis, C Souglakos, J Kakolyris, S Mavroudis, D Malamos, N Kalbakis, K Androulakis, N Agelaki, A Vardakis, N Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study, ONCOL-BASEL, 61(1), 2001, pp. 36-41
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer
Authors: Kakolyris, S Souglakos, J Kouroussis, C Androulakis, N Mavroudis, D Kalbakis, K Kotsakis, A Vardakis, N Koukourakis, M Romanos, J Georgoulias, V
Citation: S. Kakolyris et al., A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer, ONCOL-BASEL, 60(3), 2001, pp. 207-213
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
Authors: Kakolyris, S Kouroussis, C Kalbakis, K Mavroudis, D Souglakos, J Vardakis, N Kremos, S Georgoulias, V
Citation: S. Kakolyris et al., Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin, ANN ONCOL, 11(6), 2000, pp. 757-760
A dose escalation study of weekly docetaxel in patients with advanced solid tumors
Authors: Kouroussis, C Agelaki, S Mavroudis, D Souglakos, J Kakolyris, S Kalbakis, K Vardakis, N Reppa, D Hatzidaki, D Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose escalation study of weekly docetaxel in patients with advanced solid tumors, CANC CHEMOT, 46(6), 2000, pp. 488-492
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial
Authors: Mavroudis, D Kourousis, C Androulakis, N Kalbakis, K Agelaki, S Kakolyris, S Souglakos, J Sarra, E Vardakis, N Hatzidaki, D Sarmonis, G Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
Authors: Mavroudis, D Kourousis, C Kakolyris, S Agelaki, S Kalbakis, K Androulakis, N Souglakos, J Vardakis, N Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer
Authors: Kouroussis, C Androulakis, N Kakolyris, S Souglakos, J Kotsakis, T Mavroudis, D Katsogridakis, K Vardakis, N Hatzidaki, D Samonis, G Vlachonikolis, J Georgoulias, V
Citation: C. Kouroussis et al., Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer, J CL ONCOL, 17(3), 1999, pp. 862-869
Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial
Authors: Georgoulias, V Kouroussis, C Androulakis, N Kakolyris, S Dimopoulos, MA Papadakis, E Bouros, D Apostolopoulou, F Papadimitriou, C Agelidou, A Hatzakis, K Kalbakis, K Kotsakis, A Vardakis, N Vlachonicolis, J
Citation: V. Georgoulias et al., Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial, J CL ONCOL, 17(3), 1999, pp. 914-920
Risultati: 1-10 |